Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DAWN

Day One Biopharmaceuticals Inc

Sep 12 • 04:00PM ET

7.12

-0.25 -3.39 %

Healthcare • Biotechnology • USA • NASD

Peers: VRTX NBIX BPMC SRPT EXEL FATE IGMS KURA BHVN PBYI

| Held by: VTI IWM XBI VB VXF IWN VBR IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.91	Insider Own	27.13%	Shs Outstand	102.43M	Perf Week	-5.70%
Market Cap	729.32M	Forward P/E	-	EPS next Y	-0.79	Insider Trans	-0.20%	Shs Float	74.64M	Perf Month	14.65%
Enterprise Value	279.22M	PEG	-	EPS next Q	-0.29	Inst Own	74.56%	Short Float	15.11%	Perf Quarter	6.43%
Income	-95.00M	P/S	3.89	EPS this Y	-21.68%	Inst Trans	-9.37%	Short Ratio	7.42	Perf Half Y	-18.16%
Sales	187.64M	P/B	1.58	EPS next Y	36.65%	ROA	-20.66%	Short Interest	11.28M	Perf YTD	-43.80%
Book/sh	4.50	P/C	1.61	EPS next 5Y	57.50%	ROE	-24.75%	52W High	16.76 -57.52%	Perf Year	-50.35%
Cash/sh	4.42	P/FCF	-	EPS past 3/5Y	28.09% -38.09%	ROIC	-20.49%	52W Low	5.64 26.35%	Perf 3Y	-70.82%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	94.02%	Volatility	3.30% 4.22%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.49	EPS Y/Y TTM	52.85%	Oper. Margin	-59.55%	ATR (14)	0.30	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.53	Sales Y/Y TTM	2190.50%	Profit Margin	-50.63%	RSI (14)	49.88	Recom	1.20
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	-481.42%	SMA20	-1.77%	Beta	-1.26	Target Price	23.56
Payout	-	Debt/Eq	0.01	Sales Q/Q	313.92%	SMA50	3.57%	Rel Volume	0.44	Prev Close	7.37
Employees	181	LT Debt/Eq	0.01	Earnings	Aug 05 AMC	SMA200	-19.62%	Avg Volume	1.52M	Price	7.12
IPO	May 27, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	18.65% -2.93%	Trades		Volume	671,246	Change	-3.39%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-19-25	Initiated	Piper Sandler	Overweight	$25
Oct-09-24	Reiterated	Needham	Buy	$32 → $33
Aug-01-24	Upgrade	BofA Securities	Underperform → Buy	$11 → $24
Apr-24-24	Reiterated	Needham	Buy	$30 → $33
Apr-25-23	Downgrade	BofA Securities	Buy → Underperform	$34 → $9
Feb-08-23	Initiated	CapitalOne	Overweight	$40
Feb-03-23	Initiated	Oppenheimer	Perform
Dec-15-22	Initiated	H.C. Wainwright	Buy	$35
Dec-14-22	Initiated	Needham	Buy	$40
Dec-05-22	Initiated	Goldman	Buy	$45
Dec-01-22	Initiated	BofA Securities	Buy	$34

Show Previous Ratings

Sep-08-25 12:30AM	Piper Sandler Starts Coverage on Day One (DAWN) with Overweight Rating (Insider Monkey)
Aug-19-25 12:10AM	H.C. Wainwright Reiterates 'Buy' Rating on Day One Biopharmaceuticals, Inc. (DAWN) (Insider Monkey)
Aug-13-25 07:30AM	XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements (GlobeNewswire)
Aug-06-25 03:31AM	Day One Biopharmaceuticals Inc (DAWN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com) -15.70%
Aug-05-25 04:00PM	Day One Reports Second Quarter 2025 Financial Results and Corporate Progress (GlobeNewswire)
09:54AM	Loading…
Aug-04-25 09:54AM	Earnings To Watch: Day One Biopharmaceuticals Inc (DAWN) Reports Q2 2025 Result (GuruFocus.com)
Jul-24-25 09:55AM	Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 303.46%: Here's is How to Trade (Zacks)
Jul-22-25 08:30AM	Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025 (GlobeNewswire)
Jun-10-25 08:30AM	Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development (GlobeNewswire)
May-13-25 10:47AM	Is Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now? (Insider Monkey)
May-09-25 07:54AM	Is Day One Biopharmaceuticals, Inc. (DAWN) the Low Risk High Reward Stock Set to Triple by 2030? (Insider Monkey)
May-07-25 11:09AM	Q1 2025 Day One Biopharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -9.87%
03:21AM	Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
May-06-25 05:25PM	Day One Biopharmaceuticals, Inc. (DAWN) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.55%
04:01PM	Day One Reports First Quarter 2025 Financial Results and Corporate Progress (GlobeNewswire)
10:00AM	Loading…
May-05-25 10:00AM	Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Report Preview: What to Expect (GuruFocus.com) -5.67%
May-03-25 02:13AM	Q1 2025 American International Group Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-23-25 02:58PM	TimesSquare U.S. Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-22-25 08:30AM	Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025 (GlobeNewswire)
Apr-10-25 11:51PM	Day One Biopharmaceuticals Pullback Is A Potential Buying Opportunity (Seeking Alpha) -7.02% +5.33%
Apr-09-25 09:44AM	Day One Biopharmaceuticals, Inc. (DAWN): Among Stocks Under $10 that Will Triple (Insider Monkey) +8.35%
Apr-08-25 12:24AM	XOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech Twist (Seeking Alpha)
Mar-20-25 01:00AM	EXCLUSIVE: Plant Medicine Brand Apothékary Is Taking Customers on a $10,000 Immersive Trip to Japan (WWD)
Mar-05-25 09:00AM	Day One Biopharmaceuticals, Inc. (DAWN): A Bull Case Theory (Insider Monkey) +12.79%
Feb-25-25 05:55PM	Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -16.50%
04:05PM	Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress (GlobeNewswire)
01:36AM	Day One Biopharmaceuticals Inc (DAWN) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-13-25 09:55AM	Does Day One Biopharmaceuticals (DAWN) Have the Potential to Rally 193.16% as Wall Street Analysts Expect? (Zacks)
Feb-11-25 08:30AM	Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025 (GlobeNewswire)
Jan-28-25 08:56AM	Trump pledged to bring down food prices on Day One. Instead, eggs are getting more expensive (CNN Business)
05:30AM	Loading…
05:30AM	Trump said hed bring prices down on Day One. That hasnt happened (CNN Business)
Jan-23-25 01:02AM	Why Is Andreas Halvorsen Bullish On Day One Biopharmaceuticals, Inc. (DAWN) Now? (Insider Monkey)
Jan-22-25 08:44AM	New Tariffs Didnt Come on Trumps Day One. A Trade War May Not Be in the Wings. (Barrons.com)
Jan-20-25 03:31PM	President Trump outlines a frenzy of Day One executive orders and actions: Heres a list of what to expect (FastCompany)
Jan-13-25 08:00AM	Day One Reports Preliminary 2024 OJEMDA Net Product Revenue and Highlights 2025 Corporate Priorities (GlobeNewswire)
Dec-24-24 04:30PM	Are These AI Stocks Ready for a Comeback? (InvestorPlace)
Dec-22-24 03:30PM	Are These AI Stocks Ready for a Comeback? (InvestorPlace)
Dec-19-24 03:19PM	Are These AI Stocks Ready for a Comeback? (InvestorPlace)
Dec-17-24 08:30AM	Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-16-24 09:49AM	How Trump Can Help Crypto on Day One (CoinDesk)
Dec-06-24 08:53PM	Instagram locks out developers of third-party consumer apps (TechCrunch)
Nov-27-24 10:18AM	Why Is Day One Biopharmaceuticals Inc. (DAWN) Among the Best Up and Coming Stocks to Buy According to Analysts? (Insider Monkey)
Nov-20-24 04:30PM	Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development (GlobeNewswire)
Nov-18-24 08:30AM	Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-06-24 09:55AM	Wall Street Analysts See a 136.83% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High? (Zacks)
Oct-30-24 05:20PM	Day One Biopharmaceuticals, Inc. (DAWN) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:01PM	Day One Reports Third Quarter 2024 Financial Results and Corporate Progress (GlobeNewswire)
Oct-21-24 09:55AM	Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 140.71%: Read This Before Placing a Bet (Zacks)
Oct-16-24 08:44AM	Day One Biopharmaceuticals (DAWN): Advancing Targeted Therapies for Pediatric Glioma (Insider Monkey)
08:30AM	Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024 (GlobeNewswire)
Oct-01-24 08:00PM	At What Oil Price Will Shale Drillers Stop Drilling? (Oilprice.com)
Aug-27-24 12:49PM	Taylor Fritzs Girlfriend Morgan Riddle Opts for Classic Little Black Dress on Day One of the U.S. Open 2024 (WWD)
Aug-19-24 11:15AM	Jeff Bezos Said 'I Predict One Day Amazon Will Fail' And Claims Large Companies Only Last '30-Plus Years' Guess How Old Amazon Is? (Benzinga)
Aug-14-24 11:46AM	Bank of America Says Buy These 3 Stocks for a Double-Digit Rally (InvestorPlace)
Jul-30-24 01:52PM	DAWN Stock Earnings: Day One Biopharmaceutical Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
08:40AM	Day One Biopharmaceuticals, Inc. (DAWN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Day One Reports Second Quarter 2024 Financial Results and Corporate Progress (GlobeNewswire)
07:00AM	Day One Announces Oversubscribed $175.0 Million Private Placement (GlobeNewswire)
Jul-25-24 11:53AM	Ipsen outlines $461m for ex-US rights to Day Ones glioma therapy (Pharmaceutical Technology)
12:58AM	Ipsen and Day One enter into exclusive ex-U.S. licensing agreement to commercialize tovorafenib for the most common childhood brain tumor (GlobeNewswire)
Jun-27-24 09:51AM	Lupita Nyongo Shimmers in Sequined Off-the-shoulder Prada Jumpsuit and Satin Miniskirt at A Quiet Place: Day One Premiere (WWD)
Jun-24-24 04:50PM	Lupita Nyongo Gives Power Suiting a Sensual Spin in Double-breasted Blazer and High-waisted Shorts for A Quiet Place: Day One Photo Call (WWD)
Jun-22-24 04:11AM	Insider Selling: Director Saira Ramasastry Sells Shares of Day One Biopharmaceuticals Inc (DAWN) (GuruFocus.com)
Jun-19-24 12:14PM	Day One targets the growing ADC market with MabCare acquisition (Pharmaceutical Technology)
10:29AM	Day One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up (Zacks)
Jun-18-24 08:30AM	Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers (GlobeNewswire) +11.31%
Jun-11-24 07:46AM	Exclusive: Day One Ventures closes its third fund at $150 million (Fortune)
May-30-24 08:30AM	Day One Announces Sale of Priority Review Voucher for $108 Million (GlobeNewswire)
May-07-24 09:25AM	HC Wainwright Adjusts Price Target on Day One Biopharmaceuticals to $40 From $50, Maintains Buy Rating (MT Newswires)
May-06-24 10:53PM	DAWN Stock Earnings: Day One Biopharmaceutical Misses EPS for Q1 2024 (InvestorPlace)
04:30PM	Day One Reports First Quarter 2024 Financial Results and Corporate Progress (GlobeNewswire)
03:22AM	Day One Biopharmaceuticals Insider Sold Shares Worth $1,081,191, According to a Recent SEC Filing (MT Newswires)
May-04-24 02:31AM	Insider Sale at Day One Biopharmaceuticals Inc (DAWN) (GuruFocus.com)
Apr-23-24 03:56PM	Day One's OJEMDA (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor (GlobeNewswire) +8.19%
03:54PM	Day One Biopharmaceuticals Shares Rise; FDA Issues Accelerated Approval for Pediatric Low-Grade Glioma Treatment (MT Newswires)
Mar-13-24 07:07AM	13 Best Biotech Stocks To Buy Under $20 (Insider Monkey)
Feb-28-24 04:32AM	Day One Biopharmaceuticals Inc (DAWN) Reports Q4 and Full Year 2023 Financial Results (GuruFocus.com)
Feb-26-24 04:30PM	Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress (GlobeNewswire) +11.05%
Jan-31-24 05:12PM	Dwayne 'The Rock' Johnson's net worth: How the new TKO Board Member built his wealth from $7 (TheStreet)
Jan-17-24 08:00AM	Day One Announces Two New Appointments to Board of Directors (GlobeNewswire)
Dec-19-23 08:00AM	Day One to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-27-23 10:00AM	Milei to Send Shock Package to Argentinas Congress on Day One (Bloomberg)
Nov-17-23 07:00AM	Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine (GlobeNewswire)
Nov-14-23 08:00AM	Day One to Participate in the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire) +6.85%
Nov-06-23 05:16PM	Day One Biopharmaceuticals Inc (DAWN) Reports Q3 2023 Financial Results and Corporate Progress (GuruFocus.com)
04:30PM	Day One Reports Third Quarter 2023 Financial Results and Corporate Progress (GlobeNewswire)
Nov-04-23 12:16PM	12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds (Insider Monkey)
Oct-30-23 07:27PM	Apples Journal app has arrived heres whats good and bad (TechCrunch) +17.01%
08:00AM	Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) (GlobeNewswire)
Oct-23-23 01:20PM	Hedge Fund and Insider Trading News: Bill Ackman, Nelson Peltz, Dan Loeb, Coltrane Asset Management, Day One Biopharmaceuticals, Inc. (DAWN), Central Securities Corp. (CET), and More (Insider Monkey)
Oct-20-23 10:20AM	Tesla Stock Had a Horrible Day. Heres What Comes Next. (Barrons.com)
Sep-29-23 12:43PM	25 Biggest Stocks with Negative Beta (Insider Monkey)
Sep-11-23 09:02PM	Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) (GlobeNewswire)
Aug-16-23 08:00AM	Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience (GlobeNewswire)
Aug-10-23 02:28PM	FMR LLC Reduces Stake in Day One Biopharmaceuticals Inc (GuruFocus.com)
Aug-07-23 04:30PM	Day One Reports Second Quarter 2023 Financial Results and Corporate Progress (GlobeNewswire) +5.66%
Jun-17-23 08:29AM	Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) is favoured by institutional owners who hold 54% of the company (Simply Wall St.)
Jun-12-23 08:00AM	Day One Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Jun-08-23 12:38PM	Biotech Stock Roundup: GSK Provides Updates, Biogen to Discontinue Study & More (Zacks) -8.19%
07:00AM	KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA (PR Newswire)

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
York Charles N II	COO and CFO	Aug 18 '25	Sale	6.77	4,106	27,786	278,000	Aug 19 07:40 PM
Dubow Adam	Gen Counsel & Secretary	Aug 18 '25	Sale	6.77	4,365	29,538	54,858	Aug 19 07:38 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Aug 18 '25	Sale	6.77	16,058	108,666	161,365	Aug 19 07:37 PM
Merendino Lauren	Chief Commercial Officer	Aug 18 '25	Sale	6.77	3,766	25,485	41,931	Aug 19 07:36 PM
JEREMY BENDER	Officer	Aug 18 '25	Proposed Sale	6.77	16,058	108,666		Aug 18 05:33 PM
Merendino Lauren	Chief Commercial Officer	May 16 '25	Sale	6.26	3,927	24,575	35,161	May 19 05:54 PM
Dubow Adam	GENERAL COUNSEL	May 16 '25	Sale	6.26	4,552	28,486	47,136	May 19 05:48 PM
York Charles N II	COO, CFO AND SECRETARY	May 16 '25	Sale	6.26	4,282	26,796	265,231	May 19 05:45 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	May 16 '25	Sale	6.26	13,964	87,385	145,737	May 19 05:44 PM
CHARLES YORK	Officer	May 16 '25	Proposed Sale	6.26	4,282	26,796		May 16 04:09 PM
LAUREN MERENDINO	Officer	May 16 '25	Proposed Sale	6.26	3,927	24,575		May 16 04:09 PM
ADAM DUBOW	Officer	May 16 '25	Proposed Sale	6.26	4,552	28,486		May 16 04:08 PM
JEREMY BENDER	Officer	May 16 '25	Proposed Sale	6.26	13,964	87,385		May 16 04:08 PM
York Charles N II	COO, CFO AND SECRETARY	Feb 18 '25	Sale	11.96	4,370	52,278	252,638	Feb 21 06:10 PM
Dubow Adam	GENERAL COUNSEL	Feb 18 '25	Sale	11.96	4,646	55,580	39,602	Feb 21 06:08 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Feb 18 '25	Sale	11.96	12,048	144,130	128,015	Feb 21 06:05 PM
ADAM DUBOW	Officer	Feb 18 '25	Proposed Sale	11.96	4,646	55,580		Feb 18 06:07 PM
CHARLES YORK	Officer	Feb 18 '25	Proposed Sale	11.96	4,370	52,278		Feb 18 06:04 PM
JEREMY BENDER	Officer	Feb 18 '25	Proposed Sale	11.96	12,048	144,129		Feb 18 06:02 PM
Blackman Samuel C.	HEAD OF R&D	Dec 10 '24	Sale	13.31	30,000	399,339	1,034,015	Dec 12 04:06 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Nov 18 '24	Sale	13.21	10,554	139,420	108,377	Nov 19 04:36 PM
Blackman Samuel C.	HEAD OF R&D	Nov 18 '24	Sale	13.21	2,206	29,142	1,064,015	Nov 19 04:34 PM
Dubow Adam	GENERAL COUNSEL	Nov 18 '24	Sale	13.21	3,165	41,810	32,162	Nov 19 04:32 PM
York Charles N II	COO, CFO AND SECRETARY	Nov 18 '24	Sale	13.21	2,602	34,373	240,133	Nov 19 04:30 PM
SAMUEL BLACKMAN	Officer	Nov 18 '24	Proposed Sale	13.21	2,206	29,142		Nov 18 04:22 PM
JEREMY BENDER	Officer	Nov 18 '24	Proposed Sale	13.21	10,554	139,420		Nov 18 04:21 PM
Blackman Samuel C.	HEAD OF R&D	Nov 08 '24	Sale	16.17	18,255	295,229	1,067,535	Nov 12 04:57 PM
Blackman Samuel C.	HEAD OF R&D	Nov 11 '24	Sale	16.10	10,000	160,994	1,057,535	Nov 12 04:57 PM
SAMUEL BLACKMAN	Officer	Nov 11 '24	Proposed Sale	16.39	50,000	819,500		Nov 12 07:49 AM
Blackman Samuel C.	HEAD OF R&D	Nov 07 '24	Sale	16.03	11,245	180,287	1,085,790	Nov 08 04:15 PM
Blackman Samuel C.	HEAD OF R&D	Oct 31 '24	Sale	16.02	500	8,010	1,097,035	Nov 04 05:24 PM
SAMUEL BLACKMAN	Officer	Oct 31 '24	Proposed Sale	14.47	30,000	434,100		Oct 31 04:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DAWN

Day One Biopharmaceuticals Inc

Upgrade your FINVIZ experience